ChartRow logo
Data provided bySource: Twelve Data
SMMT
$10.67-9.73%
as of close, Nov 17, 2026
☾ AH $10.67 -9.73%
PeersBBIOBNTXASNDARGXGHPRAX
Share this page

Summit Therapeutics Inc. Common Stock total returns by year (including dividends)

As of market close, Nov 17, 2026

Summit Therapeutics Inc. Common Stock annual returns by year
YearTotal return
2026YTD
-39.0%
2025
-2.0%
2024
+583.7%
2023
-38.6%
2022
+58.0%
2021
-42.8%
2020
+193.8%
2019
+39.1%
2018
-89.6%
2017
+29.4%
2016
-25.6%
2015since Mar 5
+12.9%
Annualized
-1.3%
2016–2026
Average year
+70.5%
10 full years
Best year
+583.7%
2024
Worst year
-89.6%
2018
Positive years
5/10
50% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on SMMT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Summit Therapeutics Inc. Common Stock's average annual return?
Since 2016, Summit Therapeutics Inc. Common Stock (SMMT) has returned about -1.3% a year (the compound annual growth rate) and an average calendar-year return of 70.5%.
What were Summit Therapeutics Inc. Common Stock's best and worst years?
Over 2016–2026, the best year was 2024 (+583.7%) and the worst was 2018 (-89.6%).
How often is Summit Therapeutics Inc. Common Stock up in a year?
5 of the 10 full years since 2016 were positive — about 50% of the time.

More on Summit Therapeutics Inc. Common Stock